Fresenius Medical Care AG
Fresenius Medical Care AG/ DE0005785802 /
FMCQF
2024-03-14 6:18:37 PM
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
39.2100USD
|
-
|
100 Turnover: 3,921 |
-Bid Size: - |
-Ask Size: - |
11.33 bill.USD |
- |
- |
Business description
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Management board & Supervisory board
CEO |
Helen Giza |
Management board |
Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle |
Supervisory board |
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon |
Company data
Name: |
Fresenius Medical Care AG & Co. KGaA |
Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
Phone: |
+49-6172-609-0 |
Fax: |
+49-6172-609-2301 |
E-mail: |
-
|
Internet: |
www.fmc-ag.de |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
Advanced Medical Devices |
End of financial year: |
12-31 |
Free Float: |
44.95% |
IPO date: |
1996-10-02 |
Investor relations
Name: |
Dr. Dominic Heger |
IR phone: |
+49 (0) 6172 609-2525 |
IR Fax: |
+49 (0) 6172 609-2301 |
IR e-mail: |
ir@fmc-ag.com
|